Human Papillomavirus: Clinical Trials

4 trials for Human Papillomavirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Human Papillomavirus: new trials by email Literature Review of Human Papillomavirus trials Research Report on Human Papillomavirus

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Bintrafusp Alfa, PDS01ADC, Entinostat - Oropharyngeal Cancer, Neck Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)552021-10-052026-09-22
Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers
GX-I7, Placebo - Human Papillomavirus
Phase 1CompletedGenexine, Inc.322017-02-162018-10-23
A Phase I Clinical Trial of an HPV Therapeutic Vaccine
Vaccine consisting of four HPV-16 E6 peptides in combination with CandinĀ® - Human Papillomavirus
Phase 1CompletedUniversity of Arkansas522012-08-012016-10-12
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru
Gardasil - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 1CompletedPreventive Oncology International, Inc.6422011-05-012014-04-21

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Penile Neoplasms (1)  ·  Uterine Cervical Dysplasia (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Anus Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  bintrafusp alfa protein, human (1)  ·  efineptakin alfa (1)  ·  entinostat (1)

Sponsors

Genexine, Inc. (1)  ·  National Cancer Institute (NCI) (1)  ·  Preventive Oncology International, Inc. (1)  ·  University of Arkansas (1)

Countries

United States (2)  ·  Peru (1)  ·  South Korea (1)

Top investigators

Carlos Vallejos Sologuren, MD (1)  ·  Hoyoung M Maeng, M.D. (1)  ·  Jae Kwan Lee, MD, PhD (1)  ·  Jerome L Belinson, MD (1)  ·  Mayumi Nakagawa, MD, PhD (1)  ·  William W Greenfield, MD (1)

Results publications

PMID 23385153

NIH funding

R01CA143130 (1)